Acceptability of patient reported outcome measures (PROMs) in a cystic fibrosis data registry

被引:3
作者
Ratnayake, Irushi [1 ]
Ahern, Susannah [1 ]
Ruseckaite, Rasa [1 ]
机构
[1] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia
关键词
cystic fibrosis; QUALITY-OF-LIFE; HEALTH-CARE; IMPLEMENTATION; EXPERIENCES; CHILDREN;
D O I
10.1136/bmjresp-2021-000927
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction Improvements in the treatment of cystic fibrosis (CF) have resulted in longer survival and an increased focus on optimising daily functioning with the condition. Patient-reported outcome measures (PROMs) are valuable tools in evaluating the health-related quality of life of persons with chronic diseases. PROMs may be incorporated into clinical registries to assess and provide feedback regarding the health-related quality of life of the affected population. This study uses qualitative methodology to describe the views of patients with CF, caregivers and clinicians on the usefulness and practicality of incorporating a PROM in the Australian Cystic Fibrosis Data Registry (ACFDR). Methods We conducted semistructured interviews with a convenience sample of patients with CF (n=5), caregivers (n=7) and clinicians (n=13) on their opinions on incorporating the Cystic Fibrosis Questionnaire-Revised or the Cystic Fibrosis Quality of Life Questionnaire into the ACFDR. We analysed data into topics and subtopics using conventional content analysis. Results Participants believed that PROMs could generate useful aggregate health-related quality of life data to support better understanding of the experiences of the modern CF population. Participants emphasised that implementation must be supported by processes to feedback data to patients and clinicians. Most participants preferred electronic PROMs administration for easy integration into existing systems and the potential to support feedback. Conclusion Patients, caregivers and clinicians in this study generally supported the usefulness and practicality of PROM implementation in the ACFDR.
引用
收藏
页数:8
相关论文
共 39 条
  • [31] Do patient-reported outcomes have a role in the management of patients with cystic fibrosis?
    Salek, M. Sam
    Jones, S.
    Rezaie, M.
    Davies, C.
    Mills, R.
    Ketchell, R. I.
    [J]. FRONTIERS IN PHARMACOLOGY, 2012, 3
  • [32] Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO
  • [33] 2-G
  • [34] Health-related quality of life in children with cystic fibrosis: validation of the German CFQ-R
    Schmidt, Anne
    Wenninger, Kerstin
    Niemann, Nadja
    Wahn, Ulrich
    Staab, Doris
    [J]. HEALTH AND QUALITY OF LIFE OUTCOMES, 2009, 7
  • [35] Data Resource Profile: The UK Cystic Fibrosis Registry
    Taylor-Robinson, David
    Archangelidi, Olia
    Carr, Siobhan B.
    Cosgriff, Rebecca
    Gunn, Elaine
    Keogh, Ruth H.
    MacDougall, Amy
    Newsome, Simon
    Schlueter, Daniela K.
    Stanojevic, Sanja
    Bilton, Diana
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2018, 47 (01) : 9 - +
  • [36] Thompson C., 2018, AUSTR COMMISSION SAF
  • [37] Electronic real-time assessment of patient-reported outcomes in routine care first findings and experiences from the implementation in a comprehensive cancer center
    Trautmann, Freya
    Hentschel, Leopold
    Hornemann, Beate
    Rentsch, Anke
    Baumann, Michael
    Ehninger, Gerhard
    Schmitt, Jochen
    Schuler, Markus
    [J]. SUPPORTIVE CARE IN CANCER, 2016, 24 (07) : 3047 - 3056
  • [38] Integrating the Use of Patient-Reported Outcomes for Both Clinical Practice and Performance Measurement: Views of Experts from 3 Countries
    Van der Wees, Philip J.
    Nijhuis-Van der Sanden, Maria W. G.
    Ayanian, John Z.
    Black, Nick
    Westert, Gert P.
    Schneider, Eric C.
    [J]. MILBANK QUARTERLY, 2014, 92 (04) : 754 - 775
  • [39] Williams K., 2016, AUSTR COMMISSION SAF